Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
OBJECTIVE: To analyze damage occurring in patients with Wegener's granulomatosis (WG) enrolled in the WG Etanercept Trial (WGET) and to correlate that damage with disease activity, adverse events, and quality of life. METHODS: The Vasculitis Damage Index (VDI) was applied to all 180 patients a...
Asıl Yazarlar: | Seo, P, Min, Y, Holbrook, J, Hoffman, G, Merkel, P, Spiera, R, Davis, J, Ytterberg, SR, St Clair, E, McCune, W, Specks, U, Allen, N, Luqmani, R, Stone, J |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2005
|
Benzer Materyaller
-
Damage from Wegener's granulomatosis and its treatment: Prospective data from the Wegener's granulomatosis Etanercept Trial (WGET).
Yazar:: Seo, P, ve diğerleri
Baskı/Yayın Bilgisi: (2004) -
Design of the Wegener's Granulomatosis Etanercept Trial (WGET)
Yazar:: Stone, J, ve diğerleri
Baskı/Yayın Bilgisi: (2002) -
Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis
Yazar:: Falk, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011) -
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
Yazar:: Falk, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011) -
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
Yazar:: Falk, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)